POSIMIR is a Infiltration Solution in the Human Prescription Drug category. It is labeled and distributed by Innocoll Pharmaceuticals. The primary component is Bupivacaine.
| Product ID | 51715-660_efa9d516-d353-d315-e053-2a95a90ab12c |
| NDC | 51715-660 |
| Product Type | Human Prescription Drug |
| Proprietary Name | POSIMIR |
| Generic Name | Bupivacaine |
| Dosage Form | Solution |
| Route of Administration | INFILTRATION |
| Marketing Start Date | 2022-05-31 |
| Marketing Category | NDA / |
| Application Number | NDA204803 |
| Labeler Name | INNOCOLL PHARMACEUTICALS |
| Substance Name | BUPIVACAINE |
| Active Ingredient Strength | 660 mg/5mL |
| Pharm Classes | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-05-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 49396-6601 | POSIMIR | Bupivacaine |
| 51715-660 | POSIMIR | bupivacaine |
| 65250-133 | EXPAREL | bupivacaine |
| 65250-266 | EXPAREL | bupivacaine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() POSIMIR 85785555 4918452 Live/Registered |
DURECT CORPORATION 2012-11-21 |